Trends in Prescription Pain Medication Use by Race/Ethnicity Among US Adults With Noncancer Pain, 2000–2015.

• Autores: Jordan M. Harrison, Pooja Lagisetty, Brian D. Sites, Cui Guo, Matthew A. Davis
• Localización: American journal of public health, ISSN 0090-0036, Vol. 108, Nº. 6, 2018, págs. 788-790
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Objectives. To examine national trends in the use of various pharmacological pain medication classes by race/ethnicity among the US pain population. Methods. We used data from the Medical Expenditure Panel Survey to conduct a nationally representative, serial cross-sectional study of the noninstitutionalized US adult population from 2000 to 2015. We identified adults with moderate or severe self-reported pain and excluded individuals with cancer.We used complex survey design to provide national estimates of the percentage of adults with noncancer pain who received prescription pain medications among 4 groups: non-Hispanic White, non- Hispanic Black, Hispanic or Latino, and other. Results.The age- and gender-adjusted percentage of prescription opioid use increased across all groups, with the greatest increase among non-Hispanic White individuals. By 2015, the percentage of non-Hispanic Black adults using opioids approximated that of non-Hispanic White adults—in 2015, approximately 23% of adults in these 2 groups used opioids. Conclusions. To our knowledge, this is the first evidence of a narrowing divide in opioid prescribing by race. However, in the context of the national epidemic of opioid-related addiction and mortality, opioid-related risks do not appear commensurate with the purported benefits. [ABSTRACT FROM AUTHOR]